- 020 3313 1320
Lisa Pape (Hammersmith)020 3312 6806
Pauline Cleary (St Mary's)
After graduating from University College London and completing postgraduate training in the UK, Dr Mark Layton was appointed as senior lecturer and honorary consultant in the department of haematological medicine at King's College London in 1990. He was subsequently appointed as consultant haematologist and honorary reader at Hammersmith Hospital in 2000.
Sickle cell disease, thalassaemia, haemolytic anaemias, genetic disorders of red blood cells, disorders of iron metabolism
Research & publications
Dr Layton's clinical and research interests span the treatment and pathophysiology of inherited red cell disorders including being chief/principal investigator on early and pivotal clinical trials of novel disease modifiers. He is project lead for the NIHR Rare Diseases Translational Research Collaboration on haemolytic anaemia and chair of the red cell multidiscplinary team (MDT) supporting the 100,000 Genomes Project. He has authored over 100 publications in scientific journals including the New England Journal of Medicine, the Lancet, Nature Medicine, Nature Genetics and Blood.